Hematological Changes and Pregnancy Outcome in COVID-19 Pregnant Patients: A Case–Control Study

Enas Thamer; Sara Al-Rawaf

doi:10.3889/oamjms.2022.8632

Authors

Enas Thamer Department of Gynecology and Obstetrics, Al-Nahrain College of Medicine, Alnahrain University, Baghdad, Iraq https://orcid.org/0000-0002-4486-309X
Sara Al-Rawaf Department of Gynecology and Obstetrics, Al-Nahrain College of Medicine, Alnahrain University, Baghdad, Iraq

DOI:

https://doi.org/10.3889/oamjms.2022.8632

Keywords:

Hematological changes, Pregnancy outcome, COVID-19

Abstract

Background: Viral infections during pregnancy are associated with adverse maternal as well as fetal outcomes such as higher rates of miscarriage, perinatal mortality, restriction of fetal growth and preterm delivery. Aim of the study: to explore maternal outcomes and hematological alterations in a sample of Iraqi pregnant women. Patients and methods: The current cross sectional study was carried out in Obstetric department in Al Imamain Al-Kadhimain Medical City, Baghdad, Iraq, including a total of 55 full term pregnant women who were grouped into 25 women with SARS-Cov-2 and 30 control pregnant women, starting from January 2021 through December 2021. Results: Fever was the most common symptom, which was reported in 12 cases (48.0 %), and it was followed by cough that was seen in 9 cases (36.0 %). Gastrointestinal symptoms in the form of nausea, vomiting and diarrhea were seen in 2 cases (8.0 %). Leaking liquor was seen in a single case of COVID-19 women. Pregnancy induced hypertension, antepartum hemorrhage and diabetes mellitus were seen in 2 cases of COVID-19 women for each event; with no significant difference between groups. The rate of cesarean section was higher in COVID-19 group in comparison with control group, 19 (76.0 %) versus 13 (43.3 %), respectively and the difference was significant (p = 0.014). Conclusion: COVID-19 at time of pregnancy is accompanied by higher rate of cesarean section because of fetal distress with no significant increase in fetal or maternal mortality rates and the main hematological changes are leukopenia and lymphopenia.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Plum Analytics Artifact Widget Block

References

Wastnedge EA, Reynolds RM, van Boeckel SR, Stock SJ, Denison FC, Maybin JA, et al. Pregnancy and COVID-19. Physiol Rev. 2021;101(1):303-18. http://doi.org/10.1152/physrev.00024.2020 PMid:32969772 DOI: https://doi.org/10.1152/physrev.00024.2020

Cucinotta D, Vanelli M. WHO declares COVID-19 a pandemic. Acta Biomed. 2020;91(1):157-60. http://doi.org/10.23750/abm.v91i1.9397 PMid:32191675

Sekalala S, Forman L, Habibi R, Meier BM. Health and human rights are inextricably linked in the COVID-19 response. BMJ Glob Health. 2020;5(9):e003359. http://doi.org/10.1136/bmjgh-2020-003359 PMid:32938607 DOI: https://doi.org/10.1136/bmjgh-2020-003359

Wong SF, Chow KM, Leung TN, Ng WF, Ng TK, Shek CC, et al. Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome. Am J Obstet Gynecol. 2004;191(1):292-7. http://doi.org/10.1016/j.ajog.2003.11.019 PMid:15295381 DOI: https://doi.org/10.1016/j.ajog.2003.11.019

Bourne T, Kyriacou C, Coomarasamy A, Al-Memar M, Leonardi M, Kirk E, et al. ISUOG Consensus Statement on rationalization of early-pregnancy care and provision of ultrasonography in context of SARS-CoV-2. Ultrasound Obstet Gynecol. 2020;55(6):871-8. http://doi.org/10.1002/uog.22046 PMid:32267981 DOI: https://doi.org/10.1002/uog.22046

Silasi M, Cardenas I, Kwon JY, Racicot K, Aldo P, Mor G. Viral infections during pregnancy. Am J Reprod Immunol. 2015;73(3):199-213. http://doi.org/10.1111/aji.12355 PMid:25582523 DOI: https://doi.org/10.1111/aji.12355

LoMauro A, Aliverti A. Respiratory physiology of pregnancy: Physiology masterclass. Breathe (Sheff). 2015;11(4):297-301. http://doi.org/10.1183/20734735.008615 PMid:27066123 DOI: https://doi.org/10.1183/20734735.008615

Goodnight WH, Soper DE. Pneumonia in pregnancy. Crit Care Med. 2005;33 Suppl 10:S390-7. http://doi.org/10.1097/01.ccm.0000182483.24836.66 PMid:16215363 DOI: https://doi.org/10.1097/01.CCM.0000182483.24836.66

Ribes A, Vardon-Bounes F, Mémier V, Poette M, Au-Duong J, Garcia C, et al. Thromboembolic events and COVID-19. Adv Biol Regul. 2020;77:100735. http://doi.org/10.1016/j.jbior.2020.100735 PMid:32773098 DOI: https://doi.org/10.1016/j.jbior.2020.100735

Fontelo P, Bastola MM, Zheng Z, Baik SH. A review of thromboembolic events in hospitalized COVID-19 patients. Thromb J. 2021;19(1):47. http://doi.org/10.1186/s12959-021-00298-3 PMid:34187490 DOI: https://doi.org/10.1186/s12959-021-00298-3

Greer IA. Hypercoagulable states and pregnancy. Curr Hematol Rep. 2002;1(1):56-62. PMid:12901125

Matar R, Alrahmani L, Monzer N, Debiane LG, Berbari E, Fares J, et al. Clinical presentation and outcomes of pregnant women with Coronavirus disease 2019: A systematic review and meta-analysis. Clin Infect Dis. 2021;72(3):521-33. http://doi.org/10.1093/cid/ciaa828 PMid:32575114 DOI: https://doi.org/10.1093/cid/ciaa828

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. http://doi.org/10.1016/S0140-6736(20)30183-5 PMid:31986264 DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

Zaigham M, Andersson O. Maternal and perinatal outcomes with COVID-19: A systematic review of 108 pregnancies. Acta Obstet Gynecol Scand. 2020;99(7):823-9. http://doi.org/10.1111/aogs.13867 PMid:32259279 DOI: https://doi.org/10.1111/aogs.13867

Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: A systematic review and meta-analysis. CMAJ. 2021;193(16):E540-8. http://doi.org/10.1503/cmaj.202604 PMid:33741725 DOI: https://doi.org/10.1503/cmaj.202604

Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong JC, Turner AJ, et al. Angiotensin-converting enzyme 2: SARSCoV-2 receptor and regulator of the renin-angiotensin system: Celebrating the 20th anniversary of the discovery of ACE2. Circ Res. 2020;126:1456-74. http://doi.org/10.1161/CIRCRESAHA.120.317015 PMid:32264791 DOI: https://doi.org/10.1161/CIRCRESAHA.120.317015

Coronado-Arroyo JC, Concepción-Zavaleta MJ, Zavaleta-Gutiérrez FE, Concepción-Urteaga LA. Is COVID-19 a risk factor for severe preeclampsia? Hospital experience in a developing country. Eur J Obstet Gynecol Reprod Biol. 2021;256:502-3. http://doi.org/10.1016/j.ejogrb.2020.09.020 PMid:32958322 DOI: https://doi.org/10.1016/j.ejogrb.2020.09.020

Todros T, Masturzo B, de Francia S. COVID-19 infection: ACE2, pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol. 2020;253:330. http://doi.org/10.1016/j.ejogrb.2020.08.007 PMid:32863039 DOI: https://doi.org/10.1016/j.ejogrb.2020.08.007

Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: A retrospective review of medical records. Lancet. 2020;395(10226):809-15. http://doi.org/10.1016/S0140-6736(20)30360-3 PMid:32151335 DOI: https://doi.org/10.1016/S0140-6736(20)30360-3

Liu H, Liu F, Li J, Zhang T, Wang D, Lan W. Clinical and CT imaging features of the COVID-19 pneumonia: Focus on pregnant women and children. J Infect. 2020;80(5):e7-13. http://doi.org/10.1016/j.jinf.2020.03.007 PMid:32171865 DOI: https://doi.org/10.1016/j.jinf.2020.03.007

Zhang L, Jiang Y, Wei M, Cheng BH, Zhou XC, Li J, et al. Analysis of the pregnancy outcomes in pregnant women with COVID-19 in Hubei province. Zhonghua Fu Chan Ke Za Zhi. 2020;55(3):166-71. http://doi.org/10.3760/cma.j.cn112141-20200218-00111 PMid:32145714

Breslin N, Baptiste C, Gyamfi-Bannerman C, Miller R, Martinez R, Bernstein K, et al. Coronavirus disease 2019 infection among asymptomatic and symptomatic pregnant women: Two weeks of confirmed presentations to an affiliated pair of New York city hospitals. Am J Obstet Gynecol MFM. 2020;2(2):100118. http://doi.org/10.1016/j.ajogmf.2020.100118 PMid:32292903 DOI: https://doi.org/10.1016/j.ajogmf.2020.100118

Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of Coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708-20. http://doi.org/10.1056/NEJMoa2002032 PMid:32109013 DOI: https://doi.org/10.1056/NEJMoa2002032

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9. http://doi.org/10.1001/jama.2020.1585 PMid:32031570 DOI: https://doi.org/10.1001/jama.2020.1585

Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al. Clinical and immunological features of severe and moderate Coronavirus disease 2019. J Clin Invest. 2020;130(5):2620-9. http://doi.org/10.1172/JCI137244 PMid:32217835 DOI: https://doi.org/10.1172/JCI137244

Wenzhong L, Hualan L. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism, ChemRxiv; 2020. Available from: https://www.chemrxiv.org/engage/chemrxiv/article-details/60c74fa50f50db305139743d. [Last accessed on 2021 Dec 25]. DOI: https://doi.org/10.26434/chemrxiv.11938173

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054-62. http://doi.org/10.1016/S0140-6736(20)30566-3 PMid:32171076 DOI: https://doi.org/10.1016/S0140-6736(20)30566-3

Rodriguez-Morales AJ, Cardona-Ospina JA, Gutiérrez-Ocampo E, Villamizar-Peña R, Holguin-Rivera Y, Escalera-Antezana JP, et al. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Med Infect Dis. 2020;13:101623. http://doi.org/10.1016/j.tmaid.2020.101623 PMid:32179124 DOI: https://doi.org/10.1016/j.tmaid.2020.101623

Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;15:1-4. DOI: https://doi.org/10.1007/s00277-020-04019-0